Related Experiment Video
Updated: May 1, 2026

Generation of Mice Derived from Induced Pluripotent Stem Cells
Published on: November 29, 2012
Mouse SCNT ESCs have lower somatic mutation load than syngeneic iPSCs
Zhe Li1, Hongxia Lu2, Weifeng Yang2
1Division of Biological Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0322, USA ; Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0322, USA.
Somatic cell nuclear transfer embryonic stem cells (SCNT ESCs) show fewer genetic mutations than induced pluripotent stem cells (iPSCs). This suggests current iPSC reprogramming methods may introduce unique somatic mutations, impacting clinical use.
Area of Science:
- Stem Cell Biology
- Genetics
- Reproductive Biology
Background:
- Induced pluripotent stem cells (iPSCs) are generated by reprogramming somatic cells using ectopic factors.
- Concerns exist regarding genetic aberrations, such as somatic mutations, in iPSCs, potentially limiting their clinical applications.
Purpose of the Study:
- To investigate whether increased somatic mutations in iPSCs are a byproduct of current reprogramming techniques.
- To compare the mutation profiles of iPSCs and embryonic stem cells (ESCs) derived via somatic cell nuclear transfer (SCNT).
Main Methods:
- Reprogramming of mouse embryonic fibroblasts into iPSCs.
- Generation of ESCs using somatic cell nuclear transfer (SCNT ESCs).
- Exome sequencing of both iPSC and SCNT ESC lines.
Main Results:
- SCNT ESCs exhibited a significantly lower mutation load compared to iPSCs from a syngeneic background.
- One SCNT-ESC line showed no detectable exome mutations.
- Unique mutations were identified in every iPSC line, whereas SCNT-ESC lines had either no mutations or shared pre-existing mutations.
Conclusions:
- Somatic cell nuclear transfer ESCs present a lower mutation burden than iPSCs.
- Current iPSC reprogramming methods may introduce unique somatic mutations.
- Improvements in iPSC generation methods are needed for more physiologically relevant and clinically applicable cell lines.
More Related Videos
13:36Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT
Published on: September 30, 2010
10:57CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models
Published on: August 24, 2022
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
iPS Cell Differentiation
In-vitro Mutagenesis
Somatic to iPS Cell Reprogramming